Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.185
-0.055 (-4.44%)
At close: Jul 17, 2026, 4:00 PM EDT
1.220
+0.035 (2.95%)
After-hours: Jul 17, 2026, 7:55 PM EDT
Milestone Pharmaceuticals Employees
Milestone Pharmaceuticals had 38 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
38
Change
n/a
Growth
n/a
Revenue / Employee
$46,947
Profits / Employee
-$1,799,026
Market Cap
161.22M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 38 | 0 | - |
| Dec 31, 2025 | 38 | 5 | 15.15% |
| Dec 31, 2024 | 33 | -14 | -29.79% |
| Dec 31, 2023 | 47 | 8 | 20.51% |
| Dec 31, 2022 | 39 | 10 | 34.48% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 164 |
| Arcturus Therapeutics Holdings | 111 |
| Alector | 103 |
| Caribou Biosciences | 97 |
| OnKure Therapeutics | 45 |
| Corbus Pharmaceuticals Holdings | 36 |
| Jyong Biotech | 27 |
| AN2 Therapeutics | 21 |
MIST News
- 17 days ago - Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Milestone Pharmaceuticals Slides: Corporate presentation - Filings
- 2 months ago - Milestone Pharmaceuticals Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 2 months ago - Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 2 months ago - Milestone Pharmaceuticals files $300M mixed securities shelf - TheFly
- 2 months ago - Milestone Pharmaceuticals reports Q1 EPS (20c), consensus 19c - TheFly
- 2 months ago - Milestone Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Milestone Pharmaceuticals Quarterly report: Q1 2026 - Filings